Tirzepatide Cost Calculator: Plan Your Weight Loss Budget

Why Budgeting for Tirzepatide Matters Before You Start

Tirzepatide is one of the most effective weight-loss medications available today, but its price tag makes financial planning essential before you commit to treatment. Unlike a short course of antibiotics, tirzepatide is typically taken for months or years to maintain results. Without a clear budget, many patients begin treatment only to discontinue early — which wastes money and forfeits the metabolic benefits they were building toward. Understanding the full tirzepatide cost picture from the start puts you in control of the journey.

Breaking Down the Monthly Tirzepatide Cost

The list price for brand-name Mounjaro or Zepbound varies by dose. At the starting dose of 2.5 mg per week, a four-week supply of Zepbound retails for approximately $1,060 without insurance. As doses escalate — typically every four weeks — pricing stays in a similar range, roughly $1,000 to $1,100 per month regardless of strength. This is because each pen contains a fixed number of doses, and higher-dose pens are priced comparably to lower-dose pens.

Compounded Tirzepatide

During periods of FDA-declared shortage, licensed compounding pharmacies have been permitted to produce tirzepatide at significantly lower prices, often $200 to $500 per month. Compounded versions are not FDA-approved and carry regulatory uncertainty, but they have allowed millions of patients to access the drug at a fraction of the brand-name cost. Availability and legality of compounded tirzepatide changes frequently, so verify the current status with your prescriber and confirm the pharmacy holds proper state and federal accreditation.

Savings Programs and Manufacturer Coupons

Eli Lilly offers a savings card for commercially insured patients that can reduce the out-of-pocket cost of Zepbound to as low as $25 per month. This program does not apply to Medicare, Medicaid, or uninsured patients. For those without qualifying insurance, Lilly's LillyDirect program sometimes offers cash-pay pricing below the retail list price. These programs change periodically, so check the manufacturer's official savings page for current terms before relying on specific numbers.

How to Use a Tirzepatide Cost Calculator

A tirzepatide cost calculator helps you project total treatment expenses based on your dose escalation schedule, insurance situation, and treatment duration goal. To use one effectively, gather the following information first: your current insurance plan's formulary tier for tirzepatide, the deductible you must meet, your copay or coinsurance percentage after the deductible, and whether your plan imposes quantity limits or requires prior authorization. Enter those variables along with your target treatment length — commonly 12 to 24 months — and the calculator will estimate cumulative out-of-pocket spending.

A realistic 12-month estimate for a patient paying full cash price without a savings card runs between $12,000 and $13,200. A patient using the Lilly savings card with qualifying commercial insurance might pay $300 over the same period. The gap is enormous, which is why identifying your access pathway before your first injection is critical financial planning, not optional homework.

Insurance Coverage and Prior Authorization

Coverage for tirzepatide varies widely between plans. Mounjaro, approved for type 2 diabetes, is more commonly covered than Zepbound, which is approved specifically for obesity. Some patients obtain a Mounjaro prescription when they have a T2D diagnosis, while others pursue Zepbound coverage under obesity-related benefits if their plan includes them. Prior authorization almost always applies, requiring documented BMI thresholds (typically 30 or higher, or 27 with a weight-related condition), evidence of lifestyle interventions, and sometimes a record of prior medication failures.

Medicare Part D covers Zepbound as of 2026 for enrollees meeting specific criteria under the expanded obesity drug benefit. If you have Medicare, review your plan's formulary for tirzepatide cost sharing, as it will differ by plan and may still involve substantial out-of-pocket amounts during the coverage gap phase.

Building a Realistic 12-Month Budget

Start with your worst-case scenario: full list price with no assistance. Then layer in every discount you qualify for — manufacturer savings cards, pharmacy discount programs like GoodRx or Cost Plus Drugs, or employer health reimbursement arrangements. Calculate the gap between what you can reliably afford monthly and what tirzepatide actually costs under your access scenario. If that gap is significant, discuss with your prescriber whether a lower maintenance dose, extended intervals between dose increases, or a compounded option (if legally available) could reduce the monthly burden while preserving clinical benefit.

• List price (Zepbound, cash pay): approximately $1,000 to $1,100 per month
• With Lilly savings card (commercial insurance): as low as $25 per month
• Compounded tirzepatide (when available): $200 to $500 per month
• GoodRx or similar discount programs: variable, often $800 to $950 per month without insurance
• Medicare Part D (2026): plan-dependent; review your specific plan formulary

No calculator can substitute for a direct conversation with your insurance company and your prescribing clinician. Use estimated figures to frame the discussion, not to make final financial commitments. Pricing programs, insurance formularies, and regulatory status all shift — sometimes within a single plan year — so revisit your budget assumptions every three to six months to ensure the numbers still reflect your actual situation.